Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Citi
Harvard Business School
McKesson
Boehringer Ingelheim
QuintilesIMS
Cerilliant
Farmers Insurance
Baxter
Chubb

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040859

« Back to Dashboard
NDA 040859 describes NOREPINEPHRINE BITARTRATE, which is a drug marketed by Metrics Pharm, Teva Pharms Usa, Baxter Hlthcare Corp, and West-ward Pharms Int, and is included in four NDAs. It is available from three suppliers. Additional details are available on the NOREPINEPHRINE BITARTRATE profile page.

The generic ingredient in NOREPINEPHRINE BITARTRATE is norepinephrine bitartrate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.

Summary for NDA: 040859

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 040859

Ingredient-typeCatecholamines

Suppliers and Packaging for NDA: 040859

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NOREPINEPHRINE BITARTRATE
norepinephrine bitartrate
INJECTABLE;INJECTION 040859 ANDA Claris Lifesciences Inc. 36000-162 36000-162-10 10 AMPULE in 1 CARTON (36000-162-10) > 4 mL in 1 AMPULE (36000-162-01)
NOREPINEPHRINE BITARTRATE
norepinephrine bitartrate
INJECTABLE;INJECTION 040859 ANDA Cardinal Health 55154-4450 55154-4450-8 1 AMPULE in 1 BAG (55154-4450-8) > 4 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:Mar 27, 2012TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Queensland Health
Citi
McKinsey
US Army
Harvard Business School
Argus Health
Accenture
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot